Santen discussed its continued growth and expansion in ophthalmology at the European Ophthalmology Innovation Summit 2021
On 20 July 2021, Luis Iglesias, President and Head of Santen EMEA participated in a panel discussion at the European Ophthalmology Innovation Summit 2021. Luis was joined by a number of other business leaders in ophthalmology to discuss ‘What It Takes To Be Successful in the European Market’. Here Luis spoke about Santen’s recent partnerships and our ongoing focus in the adaptation and evolution of eye health therapies.
“It was a privilege to take part in this year’s European Ophthalmology Innovation Summit as a panel speaker. I had the opportunity to discuss Santen’s growth and expansion across Europe, Asia and North America,” said Luis Iglesias, President and Head of Santen EMEA. “With a proud history dating back to 1890, Santen is now the largest independent company focused entirely on ophthalmology. Our work continues to be driven by tapping into the latest advancements in ophthalmology and our desire to address the unmet needs of people with eye health or vision issues.”
To find out more about the cutting edge of ophthalmology, check out the Santen Innovation Lab series. This series offers expert perspectives and a deeper understanding of the most powerful innovations in the ever-evolving ophthalmology landscape.
